Abcam (ABCZY) Stock Price, News & Analysis

Company Overview

Abcam plc was a life sciences company that developed, manufactured and distributed biological research products. Its portfolio included primary and secondary antibodies, recombinant proteins, immunoassays, assay kits and related tools used in fields such as cell biology, immunology, neuroscience, cancer research and drug discovery.

Founded in 1998 and headquartered in Cambridge, England, Abcam served academic, pharmaceutical, biotechnology and clinical research customers internationally. The company supported researchers through direct sales, online distribution and regional operations across North America, Europe and Asia-Pacific.

Abcam became a public company in 2005 and was historically listed on the London Stock Exchange and Nasdaq. In 2023, Danaher Corporation completed its acquisition of Abcam, integrating the business into Danaher's Life Sciences segment. Before the acquisition, Abcam was led by Chief Executive Officer Alan Hirzel and had been founded by Jonathan Milner.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5,400 shs
• Average Volume: 4,712 shs
• Market Capitalization: $3.98 billion
• P/E Ratio: N/A
• Dividend Yield: 0.36%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ABCZY
• Previous Symbol: NASDAQ:ABCZY
• CIK: N/A
• Web: www.abcam.com
• Phone: 44 1223 696 000
• Fax: N/A
• Employees: 1,750
• Year Founded: 1998

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $336.37 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 205,080,000
• Free Float: N/A
• Market Cap: $3.98 billion
• Optionable: Not Optionable
• Beta: 1.29